MYC as a regulator of ribosome biogenesis and protein synthesis
The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Abstract
MYC regulates the transcription of thousands of genes required to coordinate a range of cellular processes, including those essential for proliferation, growth, differentiation, apoptosis and self-renewal. Recently, MYC has also been shown to serve as a direct regulator of ribosome biogenesis. MYC coordinates protein synthesis through the transcriptional control of RNA and protein components of ribosomes, and of gene products required for the processing of ribosomal RNA, the nuclear export of ribosomal subunits and the initiation of mRNA translation. We discuss how the modulation of ribosome biogenesis by MYC may be essential to its physiological functions as well as its pathological role in tumorigenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mechanical loading is also conveyed to the nucleolus through the transcription factor c-Myc”
From Ribosome Biogenesis as a Putative Bottleneck to Skeletal Muscle Hypertrophy: Mechanisms, Human Evidence, and Practical Modulators (2026) · cites this paper as [58]
In the citing paper
“without sufficient induction of c-Myc, the expansion of translational capacity may be limited despite favorable metabolic conditions”
From Ribosome Biogenesis as a Putative Bottleneck to Skeletal Muscle Hypertrophy: Mechanisms, Human Evidence, and Practical Modulators (2026) · cites this paper as [58]
In the citing paper
“Because this 45S transcript is rapidly processed and possesses a half-life measured in minutes, its abundance serves as an ultrasensitive, real-time indicator of active Pol I initiation and nucleolar stress [30,58].”
From Ribosome Biogenesis as a Putative Bottleneck to Skeletal Muscle Hypertrophy: Mechanisms, Human Evidence, and Practical Modulators (2026) · cites this paper as [58]
Citations
Cites
Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679
c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism
Dang, C. V. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.1 · Cited by 1,715
Max: A Helix-Loop-Helix Zipper Protein That Forms a Sequence-Specific DNA-Binding Complex with Myc
Blackwood, E. M., & Eisenman, R. N. (1991) · Science · doi:10.1126/science.2006410 · Cited by 1,697
The Myc/Max/Mad Network and the Transcriptional Control of Cell Behavior
Grandori, C., Cowley, S. M., James, L. P., & Eisenman, R. N. (2000) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.16.1.653 · Cited by 1,333
Dang, C. V., O’Donnell, K. A., Zeller, K. I., Nguyen, T., Osthus, R. C., & Li, F. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.07.014 · Cited by 1,188 · cited 1×
“The deregulated expression of Myc proteins has been implicated in the development of a wide range of cancers (reviewed in Ref”
BackgroundTranscriptional regulation and transformation by Myc proteins
Adhikary, S., & Eilers, M. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1703 · Cited by 1,131
Molecular mechanisms of translational control
Gebauer, F., & Hentze, M. W. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1488 · Cited by 991 · cited 1×
“The translational machinery is composed of ribosome subunits, mRNA, transfer RNAs (tRNAs), and translation initiation and elongation factors (reviewed in Ref”
BackgroundGenomic targets of the human c-Myc protein
Fernandez, P. C., Frank, S. R., Wang, L., Schroeder, M., Liu, S., Greene, J., Cocito, A., & Amati, B. (2003) · Genes & Development · doi:10.1101/gad.1067003 · Cited by 973
Does the ribosome translate cancer?
Ruggero, D., & Pandolfi, P. P. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1015 · Cited by 928
Cited by
Items 201–300 of 967
Jacobs, R. Q., Huffines, A. K., Laiho, M., & Schneider, D. A. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101450 · Cited by 72
Yeomans, A., Thirdborough, S. M., Valle‐Argos, B., Linley, A. J., Krysov, S. V., Sánchéz‐Hidalgo, M., Leonard, E., Ishfaq, M., Wagner, S. D., Willis, A. E., et al. (2015) · Blood · doi:10.1182/blood-2015-07-660969 · Cited by 74
Ribosome biogenesis and cancer: basic and translational challenges
Bustelo, X. R., & Dosil, M. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2017.10.003 · Cited by 65
The nucleolus, an ally, and an enemy of cancer cells
Stępiński, D. (2018) · Histochemistry and Cell Biology · doi:10.1007/s00418-018-1706-5 · Cited by 74
Targeting CLK3 inhibits the progression of cholangiocarcinoma by reprogramming nucleotide metabolism
Zhou, Q., Lin, M., Feng, X., Ma, F., Zhu, Y., Liu, X., Qu, C., Sui, H., Sun, B., Zhu, A., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20191779 · Cited by 69
Wei, Y., Zhao, L., He, W., Yang, J., Geng, C., Chen, Y., Liu, T., Chen, H., & Li, Y. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3674 · Cited by 71
Yang, J., Sung, E., Donlin-Asp, P., & Corces, V. G. (2013) · Nature Communications · doi:10.1038/ncomms2469 · Cited by 72
Gilles, A., Fréchin, L., Natchiar, K., Biondani, G., von Loeffelholz, O., Holvec, S., Malaval, J., Winum, J., Klaholz, B. P., & Peyron, J. (2020) · Cells · doi:10.3390/cells9030629 · Cited by 80
Genetic and epigenetic regulation of skeletal muscle ribosome biogenesis with exercise
Figueiredo, V. C., Wen, Y., Alkner, B., Fernandez‐Gonzalo, R., Norrbom, J., Vechetti, I. J., Valentino, T., Mobley, C. B., Zentner, G. E., Peterson, C. A., et al. (2021) · The Journal of Physiology · doi:10.1113/jp281244 · Cited by 64
Wall, M., Poortinga, G., Stanley, K. L., Lindemann, R. K., Bots, M., Chan, C. J., Bywater, M. J., Kinross, K. M., Astle, M. V., Waldeck, K., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0404 · Cited by 64
Myc-mediated SDHA acetylation triggers epigenetic regulation of gene expression and tumorigenesis
Li, S., Huang, D., Shen, S., Cai, Y., Xing, S., Wu, G., Jiang, Z., Hao, Y., Yuan, M., Wang, N., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0179-8 · Cited by 76
Enigmatic MYC Conducts an Unfolding Systems Biology Symphony
Dang, C. V. (2010) · Genes & Cancer · doi:10.1177/1947601910378742 · Cited by 65
Regulation of Ribosomal Gene Expression in Cancer
Nguyen, L. X. T., Raval, A., Garcia, J. S., & Mitchell, B. S. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24854 · Cited by 68
The crosstalk between metabolism and translation
Biffo, S., Ruggero, D., & Santoro, M. M. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.07.022 · Cited by 72
Inactivation of MYC reverses tumorigenesis
Li, Y., Casey, S. C., & Felsher, D. W. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12237 · Cited by 72
Self-citationPozzo, F., Bittolo, T., Vendramini, E., Bomben, R., Bulian, P., Rossi, F. M., Zucchetto, A., Tissino, E., Degan, M., D'Arena, G. F., et al. (2017) · Leukemia · doi:10.1038/leu.2017.90 · Cited by 66
Chen, X., & Dickman, D. (2017) · PLOS Genetics · doi:10.1371/journal.pgen.1007117 · Cited by 63
Huang, Y., Mouttet, B., Warnatz, H.-J., Risch, T., Rietmann, F., Frommelt, F., Ngo, Q. A., Dobay, M. P., Marovca, B., Jenni, S., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.10.004 · Cited by 63
Elsharawy, K. A., Mohammed, O. J., Aleskandarany, M. A., Hyder, A., El-Gammal, H., Abou-Dobara, M. I., Green, A. R., Dalton, L. W., & Rakha, E. A. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01045-7 · Cited by 62
The Role of WNT Pathway Mutations in Cancer Development and an Overview of Therapeutic Options
Groenewald, W., Lund, A. H., & Gay, D. M. (2023) · Cells · doi:10.3390/cells12070990 · Cited by 70
Sievert, H., Pällmann, N., Miller, K. K., Hermans-Borgmeyer, I., Venz, S., Sendoel, A., Preukschas, M., Schweizer, M., Böttcher, S., Janiesch, P. C., et al. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.014449 · Cited by 62
Targeted cancer therapy with ribosome biogenesis inhibitors: a real possibility?
Brighenti, E., Treré, D., & Derenzini, M. (2015) · Oncotarget · doi:10.18632/oncotarget.5775 · Cited by 69
Cowan, J. E., Malin, J., Zhao, Y., Seedhom, M. O., Harly, C., Ohigashi, I., Kelly, M. C., Takahama, Y., Yewdell, J. W., Cam, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13465-y · Cited by 60
Holmes, A. G., Parker, J. B., Sagar, V., Truica, M. I., Soni, P. N., Han, H., Schiltz, G. E., Abdulkadir, S. A., & Chakravarti, D. (2022) · Science Advances · doi:10.1126/sciadv.abh3635 · Cited by 66
Barasch, N., Gong, X., Kwei, K. A., Varma, S., Biscocho, J., Qu, K., Xiao, N., Lipsick, J. S., Pelham, R. J., West, R. B., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171265 · Cited by 62
Writing and erasing MYC ubiquitination and SUMOylation
Chen, Y., Sun, X., Sears, R. C., & Dai, M. (2019) · Genes & Diseases · doi:10.1016/j.gendis.2019.05.006 · Cited by 65
40 Years of Research Put p53 in Translation
Marcel, V., Long, F. N. V., & Diaz, J. (2018) · Cancers · doi:10.3390/cancers10050152 · Cited by 62
Dave, K., Sur, I., Yan, J., Zhang, J., Kaasinen, E., Zhong, F., Blaas, L., Li, X., Kharazi, S., Gustafsson, C., et al. (2017) · eLife · doi:10.7554/elife.23382 · Cited by 59
Pre-45s rRNA promotes colon cancer and is associated with poor survival of CRC patients
Tsoi, H., Lam, K. C., Dong, Y. J., Zhang, X., Lee, C. K., Zhang, J., Ng, S. S. S., Ng, S. S. M., Zheng, S. J., Chen, Y., et al. (2017) · Oncogene · doi:10.1038/onc.2017.86 · Cited by 61
Õunap, K., Käsper, L., Kurg, A., & Kurg, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075686 · Cited by 59
lncRNAs and MYC: An Intricate Relationship
Iaccarino, I. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071497 · Cited by 63
Nucleolar stress: Molecular mechanisms and related human diseases
Maehama, T., Nishio, M., Otani, J., Mak, T. W., & Suzuki, A. (2023) · Cancer Science · doi:10.1111/cas.15755 · Cited by 70
Chiarini, F., Lonetti, A., Teti, G., Orsini, E., Bressanin, D., Cappellini, A., Ricci, F., Tazzari, P. L., Ognibene, A., Falconi, M., et al. (2012) · Oncotarget · doi:10.18632/oncotarget.762 · Cited by 58
Popis, M. C., Blanco, S., & Frye, M. (2016) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000252 · Cited by 58
Wang, H., Lu, J. L., Edmunds, L. R., Kulkarni, S., Dolezal, J. M., Tao, J., Ranganathan, S., Jackson, L. E., Fromherz, M., Beer–Stolz, D., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.754218 · Cited by 58
Liu, S., Kim, T.-H., Franklin, D. A., & Zhang, Y. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.086 · Cited by 60
CREBBP/EP300 bromodomains are critical to sustain the GATA1/MYC regulatory axis in proliferation
García-Carpizo, V., Ruiz‐Llorente, S., Sarmentero, J., Graña‐Castro, O., Pisano, D. G., & Barrero, M. J. (2018) · Epigenetics & Chromatin · doi:10.1186/s13072-018-0197-x · Cited by 63
Implications of MYC Rearrangements in Newly Diagnosed Multiple Myeloma
Abdallah, N. H., Baughn, L. B., Rajkumar, S. V., Kapoor, P., Gertz, M. A., Dispenzieri, A. A., Lacy, M. Q., Hayman, S. R., Buadi, F. K., Dingli, D., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-2283 · Cited by 55
Ribosome biogenesis in skeletal muscle: coordination of transcription and translation
von Walden, F. (2019) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00963.2018 · Cited by 56
Combined Inactivation of CTPS1 and ATR Is Synthetically Lethal to MYC-Overexpressing Cancer Cells
Sun, Z., Zhang, Z., Wang, Q.-Q., & Liu, J.-L. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-1707 · Cited by 63
Cowling, V. H., Turner, S. A., & Cole, M. D. (2014) · Oncogene · doi:10.1038/onc.2013.338 · Cited by 56
Ribosomal protein S3 regulates GLI2-mediated osteosarcoma invasion
Nagao‐Kitamoto, H., Setoguchi, T., Kitamoto, S., Nakamura, S., Tsuru, A., Nagata, M., Nagano, S., Ishidou, Y., Yokouchi, M., Kitajima, S., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.10.042 · Cited by 55
Genotypic and Phenotypic Characteristics of Acute Promyelocytic Leukemia Translocation Variants
Mannan, A., Muhsen, I. N., Barragán, E., Sanz, M. Á., Mohty, M., Hashmi, S. K., & Aljurf, M. D. (2020) · Hematology/Oncology and Stem Cell Therapy · doi:10.1016/j.hemonc.2020.05.007 · Cited by 56
Wey, A., & Knoepfler, P. S. (2010) · Oncotarget · doi:10.18632/oncotarget.116 · Cited by 54
Human CD30+ B cells represent a unique subset related to Hodgkin lymphoma cells
Weniger, M. A., Tiacci, E., Schneider, S., Arnolds, J., Rüschenbaum, S., Duppach, J., Seifert, M., Döring, C., Hansmann, M., & Küppers, R. (2018) · Journal of Clinical Investigation · doi:10.1172/jci95993 · Cited by 66
The myonuclear DNA methylome in response to an acute hypertrophic stimulus
Von Walden, F., Rea, M., Mobley, C. B., Fondufe-Mittendorf, Y., McCarthy, J. J., Peterson, C. A., & Murach, K. A. (2020) · Epigenetics · doi:10.1080/15592294.2020.1755581 · Cited by 53
Hoose, S. A., Rawlings, J. A., Kelly, M. M., Leitch, M. C., Ababneh, Q., Robles, J. P., Taylor, D. W., Hoover, E. M., Hailu, B., McEnery, K., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002590 · Cited by 59
Superresolution microscopy reveals linkages between ribosomal DNA on heterologous chromosomes
Potapova, T., Unruh, J. R., Yu, Z., Rancati, G. I., Li, H., Stampfer, M. R., & Gerton, J. L. (2019) · The Journal of Cell Biology · doi:10.1083/jcb.201810166 · Cited by 55
Liao, P., Wang, W., Shen, M., Pan, W., Zhang, K., Wang, R., Chen, T., Chen, Y., Chen, H., & Wang, P. (2014) · Cell Death and Disease · doi:10.1038/cddis.2013.536 · Cited by 54
Kimura, S., Montefiori, L. E., Iacobucci, I., Zhao, Y., Gao, Q., Paietta, E. M., Haferlach, C., Laird, A., Mead, P. E., Gu, Z., et al. (2022) · Blood · doi:10.1182/blood.2022015444 · Cited by 57
Overexpression of the c-myc Oncogene Inhibits Nonsense-mediated RNA Decay in B Lymphocytes
Wang, D., Wengrod, J., & Gardner, L. B. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.266361 · Cited by 52
snoRNAs are a novel class of biologically relevant Myc targets
Herter, E. K., Stauch, M., Gallant, M., Wolf, E., Raabe, T., & Gallant, P. (2015) · BMC Biology · doi:10.1186/s12915-015-0132-6 · Cited by 53
The tumor suppressor role of CTCF
Fiorentino, F. P., & Giordano, A. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22780 · Cited by 59
Regulation of c-Myc protein stability by proteasome activator REGγ
Li, S., Jiang, C., Pan, J., Wang, X., Jin, J., Zhao, L., Pan, W., Liao, G., Cai, X., Li, X., et al. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.188 · Cited by 52
MYC in Germinal Center‐derived lymphomas: Mechanisms and therapeutic opportunities
Bisso, A., Sabò, A., & Amati, B. B. (2019) · Immunological Reviews · doi:10.1111/imr.12734 · Cited by 57
TAF5L and TAF6L Maintain Self-Renewal of Embryonic Stem Cells via the MYC Regulatory Network
Seruggia, D., Oti, M., Tripathi, P., Canver, M. C., LeBlanc, L., Di Giammartino, D. C., Bullen, M. J., Nefzger, C. M., Sun, Y. B. Y., Farouni, R., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.03.025 · Cited by 51
The ATPase hCINAP regulates 18S rRNA processing and is essential for embryogenesis and tumour growth
Bai, D., Zhang, J., Li, T., Hang, R., Liu, Y., Tian, Y., Huang, D., Qu, L., Cao, X., Ji, J., et al. (2016) · Nature Communications · doi:10.1038/ncomms12310 · Cited by 57
Ribosomal Protein S12e Has a Distinct Function in Cell Competition
Kale, A., Ji, Z., Kiparaki, M., Blanco, J., Rimesso, G., Flibotte, S., & Baker, N. E. (2018) · Developmental Cell · doi:10.1016/j.devcel.2017.12.007 · Cited by 60
Poole, C. J., Lodh, A., Choi, J.-H., & van Riggelen, J. (2019) · Epigenetics & Chromatin · doi:10.1186/s13072-019-0278-5 · Cited by 52
Interaction between MYC and MCL1 in the Genesis and Outcome of Non–Small-Cell Lung Cancer
Allen, T. D., Zhu, C., Jones, K. D., Yanagawa, N., Tsao, M., & Bishop, J. M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3590 · Cited by 52
MAD1 and its life as a MYC antagonist: An update
Lüscher, B. (2011) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2011.07.005 · Cited by 56
A mouse model of MYCN-driven retinoblastoma reveals MYCN-independent tumor reemergence
Wu, N., Jia, D., Bates, B. M., Basom, R., Eberhart, C. G., & MacPherson, D. P. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88508 · Cited by 51
MYC-induced metabolic stress and tumorigenesis
Wolpaw, A. J., & Dang, C. V. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.05.003 · Cited by 57
Bionaz, M., Monaco, E. L., & Wheeler, M. B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137644 · Cited by 49
A role for c-Myc in regulating anti-mycobacterial responses
Yim, H. C. H., Li, J., Pong, J. C. H., & Lau, A. S. Y. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104892108 · Cited by 47
Histone Deacetylase 3 Is Required for Efficient T Cell Development
Stengel, K. R., Zhao, Y., Klus, N. J., Kaiser, J. F., Gordy, L. E., Joyce, S., Hiebert, S. W., & Summers, A. R. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00706-15 · Cited by 48
Jaiswal, P. K., Koul, S., Palanisamy, N., & Koul, H. K. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0947-2 · Cited by 50
Comparative Study of Organoids from Patient-Derived Normal and Tumor Colon and Rectal Tissue
Costales-Carrera, A., Fernández-Barral, A., Bustamante-Madrid, P., Domínguez, O., Guerra-Pastrián, L., Cantero, R., del Peso, L., Burgos, A., Barbáchano, A., & Muñoz, A. (2020) · Cancers · doi:10.3390/cancers12082302 · Cited by 47
Deubiquitinating c-Myc: USP36 steps up in the nucleolus
Sun, X., Sears, R. C., & Dai, M. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1093713 · Cited by 48
miRConnect: Identifying Effector Genes of miRNAs and miRNA Families in Cancer Cells
Hua, Y., Duan, S., Murmann, A. E., Larsen, N., Kjems, J., Lund, A. H., & Peter, M. E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026521 · Cited by 50
Sirozh, O., Sáez-Mas, A., Jung, B., Sanchez‐Burgos, L., Zarzuela, E., Rodrigo-Perez, S., Ventoso, I., Lafarga, V., & Fernández-Capetillo, Ó. (2024) · Molecular Cell · doi:10.1016/j.molcel.2024.02.031 · Cited by 51
Pathogenesis and therapeutic targeting of aberrant MYC expression in haematological cancers
Schick, M., Habringer, S., Nilsson, J. A., & Keller, U. B. (2017) · British Journal of Haematology · doi:10.1111/bjh.14917 · Cited by 47
Niemas-Teshiba, R., Matsuno, R., Wang, L. L., Tang, X. X., Chiu, B., Zeki, J. C., Coburn, J. M., Ornell, K. J., Naranjo, A. H., Ryn, C. V., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.23740 · Cited by 46
TRIM6 interacts with c-Myc and maintains pluripotency of mouse embryonal stem cells
Sato, T. Z., Okumura, F., Ariga, T., & Hatakeyama, S. (2012) · Journal of Cell Science · doi:10.1242/jcs.095273 · Cited by 54
Wang, H. Q., Halilovic, E., Li, X., Liang, J., Cao, Y., Rakiec, D. P., Ruddy, D. A., Jeay, S., Wuerthner, J. U., Timple, N., et al. (2017) · eLife · doi:10.7554/elife.17137 · Cited by 45
Multiple Roles of MYC in Integrating Regulatory Networks of Pluripotent Stem Cells
Fagnocchi, L., & Zippo, A. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00007 · Cited by 45
Brook, M. S., Wilkinson, D. J., Smith, K., & Atherton, P. J. (2019) · European Journal of Sport Science · doi:10.1080/17461391.2019.1569726 · Cited by 45
Proteome and Phosphoproteome Changes Associated with Prognosis in Acute Myeloid Leukemia
Aasebø, E., Berven, F. S., Bartaula-Brevik, S., Stokowy, T., Hovland, R., Vaudel, M., Døskeland, S. O., McCormack, E., Batth, T. S., Olsen, J. V., et al. (2020) · Cancers · doi:10.3390/cancers12030709 · Cited by 44
Yan, Y., Zhou, B. O., Chen, Q., Vasquez, A., Kamra, M., Chatterjee, A., Lee, Y., Yuan, X., Ellis, L., Vizio, D. D., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28340-6 · Cited by 48
Lafita‐Navarro, M. C., Kim, M., Borenstein‐Auerbach, N., Venkateswaran, N., Hao, Y.-H., Ray, R., Brabletz, T., Scaglioni, P. P., Shay, J. W., & Conacci‐Sorrell, M. (2018) · Genes & Development · doi:10.1101/gad.313007.118 · Cited by 54
Fibrocytes Regulate Wilms Tumor 1–Positive Cell Accumulation in Severe Fibrotic Lung Disease
Sontake, V., Shanmukhappa, S. K., DiPasquale, B. A., Reddy, G. B., Medvedovic, M., Hardie, W. D., White, E. S., & Madala, S. K. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500963 · Cited by 47
Technical Advance: Immunophenotypical characterization of human neutrophil differentiation
Mora-Jensen, H. I., Jendholm, J., Fossum, A., Porse, B. T., Borregaard, N., & Theilgaard‐Mönch, K. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0311123 · Cited by 46
Disruption of the RP-MDM2-p53 pathway accelerates APC loss-induced colorectal tumorigenesis
Liu, S., Tackmann, N. R., Yang, J., & Zhang, Y. (2016) · Oncogene · doi:10.1038/onc.2016.301 · Cited by 45
Molecular markers of paragangliomas/pheochromocytomas
Zhikrivetskaya, S. O., Snezhkina, A. V., Zaretsky, A. R., Alekseev, B. Y., Pokrovsky, A. V., Golovyuk, A. L., Melnikova, N. V., Stepanov, O. A., Kalinin, D. V., Moskalev, A., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15201 · Cited by 45
Nasrabadi, P. N., Zareian, S., Nayeri, Z., Salmanipour, R., Parsafar, S., Gharib, E., Aghdaei, H. A., & Zali, M. R. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28204 · Cited by 43
Veo, B. L., Danis, E. P., Pierce, A. M., Wang, D., Fosmire, S. P., Sullivan, K. D., Joshi, M., Khanal, S., Dahl, N. A., Karam, S. D., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109013 · Cited by 55
Specialized Ribosomes in Health and Disease
Miller, S. C., MacDonald, C. C., Kellogg, M. K., Karamysheva, Z. N., & Karamyshev, A. L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076334 · Cited by 42
Ribosome-Directed Therapies in Cancer
Temaj, G., Chichiarelli, S., Eufemi, M., Fabio Altieri, F., Hadžiselimović, R., Farooqi, A. A., Yaylım, İ., & Saso, L. (2022) · Biomedicines · doi:10.3390/biomedicines10092088 · Cited by 47
MYC—an emerging player in mitochondrial diseases
Purhonen, J., Klefström, J. T., & Kallijärvi, J. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1257651 · Cited by 43
Histone deacetylase 5 blocks neuroblastoma cell differentiation by interacting with N-Myc
Sun, Y., Liu, P. Y., Scarlett, C. J., Malyukova, A., Liu, B., Marshall, G. M., MacKenzie, K. L., Biankin, A. V., & Liu, T. (2013) · Oncogene · doi:10.1038/onc.2013.253 · Cited by 45
Bouteiller, M. L., Souilhol, C., Beck-Cormier, S., Stedman, A., Burlen‐Defranoux, O., Vandormael‐Pournin, S., Bernex, F., Cumano, A., & Cohen‐Tannoudji, M. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20122019 · Cited by 49
Alterations in Ca2+ Signalling via ER-Mitochondria Contact Site Remodelling in Cancer
Kerkhofs, M., Giorgi, C., Marchi, S., Seitaj, B., Parys, J. B., Pinton, P., Bultynck, G., & Bittremieux, M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-4567-7_17 · Cited by 50
van den Heuvel, J., Ashiono, C., Gillet, L. C. J., Dörner, K., Wyler, E., Zemp, I., & Kutay, U. (2021) · eLife · doi:10.7554/elife.70560 · Cited by 41
Gerometabolites: The pseudohypoxic aging side of cancer oncometabolites
MENENDEZ MENENDEZ, J., ALARCÓN, T., & Joven, J. (2014) · Cell Cycle · doi:10.4161/cc.28079 · Cited by 40
Stromal EGF and IGF-I Together Modulate Plasticity of Disseminated Triple-Negative Breast Tumors
Castaño, Z., Marsh, T., Tadipatri, R., Kuznetsov, H. S., Al‐Shahrour, F., Paktinat, M., Greene-Colozzi, A., Nilsson, B., Richardson, A. L., & McAllister, S. S. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0041 · Cited by 47
Targeting the Ribosome Biogenesis Key Molecule Fibrillarin to Avoid Chemoresistance
Hassouni, B. E., Sarkisjan, D., Vos, J. C., Giovannetti, E., & Peters, G. J. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867326666181203133332 · Cited by 50
c-MYC regulates mRNA translation efficiency and start-site selection in lymphoma
Singh, K., Lin, J., Zhong, Y., Burčul, A., Mohan, P., Jiang, M., Sun, L. L., Yong‐Gonzalez, V., Viale, A. J., Cross, J. R., et al. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20181726 · Cited by 45
The role of MYC in the transformation and aggressiveness of ‘indolent’ B-cell malignancies
Filip, D., & Mráz, M. (2019) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2019.1675877 · Cited by 48
A super-enhancer-regulated RNA-binding protein cascade drives pancreatic cancer
Antal, C. E., Oh, T. G., Aigner, S., Luo, E., Yee, B. A., Campos, T., Tiriac, H., Rothamel, K. L., Zhang, C., Jiao, H., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40798-6 · Cited by 42
Jung, J. H., Lee, H., Kim, J., Sim, D. Y., Im, E., Kim, S., Chang, S., & Kim, S. (2020) · Cells · doi:10.3390/cells9040985 · Cited by 38
Metadata
- Authors
- van Riggelen, J., Yetil, A., & Felsher, D. W.
- Affiliations
- Stanford Medicine (US)
- Corresponding author
- Felsher, Dean W.
- ORCID
- Felsher, Dean W.
- Venue
- Nature Reviews Cancer
- Published
- 2010-04
- Volume
- 10
- Issue
- 4
- Pages
- 301-309
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2021764678
- Cited by
- 956
- References
- 126
- Citations by year
- 2026: 59 · 2025: 65 · 2024: 94 · 2023: 72 · 2022: 61 · 2021: 68 · 2020: 75 · 2019: 63 · 2018: 50 · 2017: 57 · 2016: 48 · 2015: 57 · 2014: 53 · 2013: 43 · 2012: 39
- FWCI
- 3.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Burroughs Wellcome Fund
- Leukemia and Lymphoma Society
- Canada Research Chairs
- National Institutes of Health
- Canadian Institutes of Health Research
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- c-Myc, ribosome biogenesis, protein synthesis, rRNA processing, translation initiation, transcriptional regulation, carcinogenesis, cell proliferation
- MeSH terms
- Gene Expression Regulation, Homeostasis, Humans, Models, Genetic, Neoplasms, Ribosomal Proteins, Ribosomes, RNA, Messenger, Protein Biosynthesis, Genes, myc, Proto-Oncogene Proteins c-myc
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.